Saltar al contenido
Merck

A simple protocol to produce mature human-induced pluripotent stem cell-derived cardiomyocytes.

STAR protocols (2021-11-11)
Walter E Knight, Yingqiong Cao, Phoebe Dillon, Kunhua Song
RESUMEN

When cultured under typical conditions, human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are structurally and functionally immature. We have previously demonstrated that culture of hiPSC-CMs in maturation medium containing fatty acids, in combination with culture on micropatterned surfaces, produces cells that demonstrate a more mature phenotype compared to standard approaches. Here, we show in detail the steps needed to produce mature hiPSC-CMs. Compared with many approaches, our protocol is relatively simple and can be easily adapted to new laboratories. For complete details on the use and execution of this protocol, please refer to Knight et al. (2021).

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Cóctel de inhibidores de proteasas, for use with mammalian cell and tissue extracts, DMSO solution
Sigma-Aldrich
Sacarosa, for molecular biology, ≥99.5% (GC)
Sigma-Aldrich
MOPS, ≥99.5% (titration)
Sigma-Aldrich
Gelatina from porcine skin, gel strength 300, Type A
Sigma-Aldrich
Anti-α-actinina (sarcomérica) monoclonal antibody produced in mouse, clone EA-53, ascites fluid
Sigma-Aldrich
Hidróxido de potasio, BioXtra, ≥85% KOH basis
Sigma-Aldrich
Triton X-100, laboratory grade
Millipore
EDTA, ULTROL® Grade, 500 mM Solution, pH 8.0
Sigma-Aldrich
Urea, ACS reagent, 99.0-100.5%
Sigma-Aldrich
Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid, ≥97.0%